07.09.2011Augurix and Tillotts sign agreement for the commercialization of Simtomax.You are hereNewsAugurix and Tillotts sign agreement for the commercialization of Simtomax.
Augurix and Tillotts sign agreement for the commercialization of Simtomax® for rapid diagnosis of celiac disease.
Find an actor
LS2 Annual Meeting 201812.02.2018The biggest Life Sciences conference in Switzerland takes place at the University of Lausanne February 12-13, 2018
Bilan - Les Métiers de DemainLe magazine référence nous informe des nouvelles formations et de leur impact sur l'avenir des métiers de la santé...
Intrace Medical SAMedical technology, Diagnostic & Therapeutic Devices / Imaging
Intrace Medical develops innovative fluorescent and bioluminescent probes for medical Imaging, including medical diagnostics and image-guided surgery.
Therapeutics & Diagnostics, Chemical Drug, small Molecules
Intrace Medical can also develop customized Imaging probes according to specific research or medical needs.
These probes can be used for cell-based assays, preclinical studies and clinical trials (the ICG molecule is one of the few fluorophores accepted for clinical use).
Primary applications include oncology and bacterial infection.